Ferozsons Laboratories (KAR:FEROZ) ROCE %: 11.37% (As of Mar. 2026)


KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
76 GF Score
Price ₨411.15
GF Value ₨418.18
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Ferozsons Laboratories ROCE %?

Ferozsons Laboratories KAR:FEROZ -0.17% 76 ROCE % is 11.37% as of Mar. 2026. GuruFocus rates KAR:FEROZ with a GF Score™ of 76/100 and a GF Value™ of ₨418.18 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ferozsons Laboratories's annualized ROCE % for the quarter that ended in Mar. 2026 was 11.37%.

Ferozsons Laboratories  (KAR:FEROZ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ferozsons Laboratories ROCE % Related Terms

Ferozsons Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Ferozsons Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories ROCE % Chart

Ferozsons Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.23 13.19 6.55 13.36 12.53

Ferozsons Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.46 12.10 14.23 15.85 11.37
KAR:FEROZ
76GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ferozsons Laboratories ROCE % Calculation

Ferozsons Laboratories's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=2106.157/( ( (21749.622 - 6084.929) + (24604.947 - 6652.114) )/ 2 )
=2106.157/( (15664.693+17952.833)/ 2 )
=2106.157/16808.763
=12.53 %

Ferozsons Laboratories's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2077.864/( ( (26756.019 - 8552.645) + (26462.806 - 8106.582) )/ 2 )
=2077.864/( ( 18203.374 + 18356.224 )/ 2 )
=2077.864/18279.799
=11.37 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.37% mean?
Ferozsons Laboratories (KAR:FEROZ) has a ROCE % of 11.37% as of Mar. 2026.
Is Ferozsons Laboratories' ROCE % too high?
Ferozsons Laboratories' current ROCE % is 11.37%. The Drug Manufacturers industry median ROCE % is 7.03. Ferozsons Laboratories' value of 11.37% is 61.7% above this industry median. Overall, Ferozsons Laboratories has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' ROCE % compare to ZTS and UTHR?
Ferozsons Laboratories' ROCE % of 11.37% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Ferozsons Laboratories' value of 11.37% is 61.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ferozsons Laboratories's current ROCE % of 11.37% is 61.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ferozsons Laboratories's current ROCE % is 11.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Fairly Valued. The stock's GF Value™ is ₨418.18, compared to a current price of ₨411.15 — trading 1.7% below its estimated fair value. The current ROCE % is 11.37% and 61.7% above the Drug Manufacturers industry median of 7.03. Ferozsons Laboratories' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current ROCE % is 11.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨411.15 is trading 1.7% below its estimated GF Value™ of ₨418.18. GuruFocus considers Ferozsons Laboratories to be Fairly Valued.

Key valuation signals for KAR:FEROZ:

  • ROCE %: 11.37%
  • GF Value™: ₨418.18 vs. price of ₨411.15 (1.7% below fair value)
  • GF Score™: 76/100 with 5 warning signs
  • Industry Position: 61.7% above the Drug Manufacturers median

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
76GF Score

Get the complete analysis for KAR:FEROZ

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨411.15
Price
₨418.18
GF Value